Dragon Life Science Holdings Group, Inc.
NOHO
$0.00
$0.000.00%
| 05/31/2014 | 02/28/2014 | 11/30/2013 | 08/31/2013 | 05/31/2013 | |
|---|---|---|---|---|---|
| Revenue | 90.67% | 128.30% | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 90.67% | 128.30% | -- | -- | -- |
| Cost of Revenue | -1.96% | -44.98% | -- | -- | -- |
| Gross Profit | 113.57% | 256.09% | -- | -- | -- |
| SG&A Expenses | 21.78% | -58.24% | 13.15% | -62.81% | -67.87% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29.01% | -53.69% | 33.25% | -61.79% | -64.53% |
| Operating Income | 26.67% | 91.97% | 80.49% | 70.13% | 81.36% |
| Income Before Tax | -9,136.86% | 2.66% | -241.15% | 46.73% | -148.30% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9,136.86% | 2.66% | -241.15% | 46.73% | -148.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9,136.86% | -70.85% | -241.15% | 46.31% | -148.30% |
| EBIT | 26.67% | 91.97% | 80.49% | 70.13% | 81.36% |
| EBITDA | 44.85% | 96.33% | 93.13% | 70.94% | 81.38% |
| EPS Basic | -33.33% | 99.00% | 87.21% | 68.89% | -107.69% |
| Normalized Basic EPS | 81.25% | 96.43% | 87.04% | 75.78% | 92.56% |
| EPS Diluted | -33.33% | 99.00% | 87.21% | 68.89% | -107.69% |
| Normalized Diluted EPS | 81.25% | 96.43% | 87.04% | 75.78% | 92.56% |
| Average Basic Shares Outstanding | 7,101.23% | 18,252.73% | 2,658.20% | 71.61% | 457.99% |
| Average Diluted Shares Outstanding | 7,101.23% | 18,252.73% | 2,658.20% | 71.61% | 457.99% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
